Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2008
10/21/2008US7438928 Topical gel matrix
10/21/2008US7438927 Methods of treatment using a gastric retained gabapentin dosage
10/21/2008US7438924 Dry granulated formulations of azithromycin
10/21/2008US7438903 Fine particle sizes; nanostructure; in mixture with oil, water carriers, excipients; oral diseases; cognition activators; hypotensive agents; immunology diseases; blood disorders
10/21/2008US7438900 Dendritic encapsulation of active agents
10/21/2008US7438890 Binding peptides for carcinoembryonic antigen (CEA)
10/21/2008US7438203 Dermal penetration enhancers and drug delivery systems involving same
10/21/2008CA2468847C Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
10/21/2008CA2412708C Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
10/21/2008CA2390284C Apparatus and method for preparing microparticles
10/21/2008CA2387383C Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
10/21/2008CA2359488C Inorganic shaped bodies and methods for their production and use
10/21/2008CA2351947C Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
10/21/2008CA2351484C Method of producing solid dosage forms
10/21/2008CA2341646C Method for producing solid dosing forms
10/21/2008CA2333648C Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
10/21/2008CA2282345C Pharmaceutical composition
10/21/2008CA2247998C Fragments of cr1 and their use
10/21/2008CA2166108C Insulin preparations for inhalation
10/16/2008WO2008124735A2 Multi-functional polyglutamate drug carriers
10/16/2008WO2008124617A2 Rapidly dissolving pharmaceutical compositions comprising pullulan
10/16/2008WO2008124165A2 Self-assembling nanoparticle drug delivery system
10/16/2008WO2008124013A1 Novel formulations for delivery of antiviral peptide therapeutics
10/16/2008WO2008123798A1 Solid nanocomposition for delivering biologically active substances
10/16/2008WO2008123797A1 Nanoemulsion with biologically active agents
10/16/2008WO2008123471A1 Composition for cleaning nasal fossa
10/16/2008WO2008123396A1 Suspension-type eye drop preparation comprising fluorometholone
10/16/2008WO2008122993A1 Controlled release formulation of coated microparticles
10/16/2008WO2008122741A1 Conjugated fatty acids and poly-l-lysine for combating pathogenic micro-organisms
10/16/2008WO2008122415A1 Stable aqueous g-csf formulations
10/16/2008WO2008122398A1 Biologically degradable multilayer system
10/16/2008WO2008122192A1 Liposomal pharmaceutical carrier and process for preparation thereof
10/16/2008WO2008101173A3 Biodegradable compositions and materials
10/16/2008WO2008093221A3 Pharmaceutical compositions containing pde4 inhibitor for the treatment of inflammatory and allergic disorders
10/16/2008WO2008086395A3 Anti-il-13 antibody formulations and uses thereof
10/16/2008WO2008058547A3 Alpha-lactalbumin composition
10/16/2008WO2008058125A3 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
10/16/2008WO2008045373A3 Stable antibody formulations
10/16/2008WO2008038147A3 Foamable vehicle comprising dicarboxylic acid or dicarboxylic acid ester and pharmaceutical compositions thereof
10/16/2008WO2007134595A3 Novel formulation, oriented to tumour physiology, of a cytostatic, in particular of cis-platinum
10/16/2008WO2007022239A3 Pharmaceutical formulations for sustained drug delivery
10/16/2008US20080255250 Compounds and Compositions for Delivering Active Agents
10/16/2008US20080255248 Coupling a stabilizing group-oligopeptide conjugate with the free therapeutic agent, binding with a polymeric resin forming a therapeutic agent-polymeric resin complex; high specificity of action, a reduced toxicity, an improved stability in the serum and blood
10/16/2008US20080255235 Inhibitor of a Levodopa-metabolising enzyme, a buffer, a sugar, an acid; Parkinson's disease
10/16/2008US20080255227 7-[(1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo[4.3.0]nonane-8-one-7-yl]heptanoic acid and a glyceride; improved stability
10/16/2008US20080255125 Topically Applied Medicament for Animals
10/16/2008US20080255104 Nsaid Compositions
10/16/2008US20080255073 Compounds for sustained release of orally delivered drugs
10/16/2008US20080254127 Inhalation particles incorporating a combination of two or more active ingredients
10/16/2008US20080254124 Controlled release composition
10/16/2008US20080254115 Arcuate surface structure; matrix release characteristics; capable of high dosage delivery; usable for sustained, pulsatile, enteric and immediate release drug formulations
10/16/2008US20080254113 Microemulsion Formulations Comprising Particular Substance P Antagonists
10/16/2008US20080254112 Pharmaceutical Active-Ingredient-Containing Formulation with Coating
10/16/2008US20080254111 Vinyl alcohol polymer; nonleaking; preventing oxygen and water entry
10/16/2008US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
10/16/2008US20080254103 Wound Dressings Comprising a Protein Polymer and a Polyfunctional Spacer
10/16/2008US20080254099 Pharmaceutical Compositions Comprising Polymeric Binders with Non-Hydrolysable Covalent Bonds and Their Use in Treating Celiac Disease
10/16/2008US20080254094 Biomaterials Carrying Cyclodextrines Having Improved Absorption Properties and Used for the Progressive and Delayed Release of Therapeutic Molecules
10/16/2008US20080254088 Crosslinked gelatin and a plasticizer stretched to orient the gelatin molecules, preferably uniaxial; high mechanical strength and flexibility; improving tear strength/elongation; bioresorbable; surgery; grafting; drug delivery; tissue engineering; nerve guides; wound coverings; stability; carriers
10/16/2008US20080254078 Simple, binary system of hydrophilic nanoparticles using cationic chitosan and anionic polysaccharides having carboxymethyl groups and/or sulfate groups; adjustable zeta potential of aqueous colloidal suspensions; binding biological groups covalently; drug delivery; foods; cosmetics; biocompatability
10/16/2008US20080254076 Composition based on silicone oil structured in rigid form, especially for cosmetic use
10/16/2008US20080254057 Minimizing carrier-induced epitopic suppression in combination vaccines by minimizing the amount of unconjugated carrier protein; vaccines based on conjugated capsular saccharides from multiple serogroups
10/16/2008US20080253990 Using thymidine defective grampositive microorganism to deliver interleukin therapeutic for use in treatment of inflammatory bowel disease
10/16/2008US20080253971 Particles for inhalation having sustained release properties
10/16/2008US20080253969 Multi-functional polyglutamate drug carriers
10/16/2008US20080253960 Cell surface receptor ligand is covalently bonded to apoprotein; photodynamic therapy; antiglaucoma agents
10/16/2008CA2683063A1 Self-assembling nanoparticle drug delivery system
10/16/2008CA2682848A1 Novel formulations for delivery of antiviral peptide therapeutics
10/16/2008CA2682752A1 Rapidly dissolving pharmaceutical compositions comprising pullulan
10/16/2008CA2679551A1 Stable aqueous g-csf formulations
10/15/2008EP1980572A1 Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
10/15/2008EP1980278A2 Drug coating with top coat
10/15/2008EP1980272A2 Orally-disintegrating tablet and manufacturing method thereof
10/15/2008EP1980271A1 Medicine for transnasal administration
10/15/2008EP1980256A1 OIL-IN-WATER TYPE EMULSION LOTION CONTAINING 22-OXA-1 alpha ,25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATING SKIN DISEASE BY USING THE SAME
10/15/2008EP1980243A1 Liposome preparation
10/15/2008EP1979407A1 Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers
10/15/2008EP1979269A2 Chlorite formulations, and methods of preparation and use thereof
10/15/2008EP1979003A1 Method for deriving a wellness related index for a food composition
10/15/2008EP1978973A2 Methods of using hedgehog kinase antagonists to inhibit hedgehog signaling and to treat hedgehog mediated disorders
10/15/2008EP1978953A1 Pharmaceutical compositions containing docetaxel and a degradation inhibitor and a process for obtaining the same.
10/15/2008EP1978938A1 Process for loading polymer particles with drug
10/15/2008EP1978937A1 Use of amphiphilic self-assembling proteins for formulating poorly water-soluble effect substances
10/15/2008EP1978931A1 Composition for promoting vascular smooth muscle relaxation
10/15/2008EP1978927A1 Pharmaceutical forms in film form for use in the mouth (wafer)
10/15/2008EP1742642B1 Phosphonate analogs of hiv integrase inhibitor compounds
10/15/2008EP1713505B1 Method of preparation of a fungal glucane hydrogel having antibacterial and immunostimulant activity, and use thereof
10/15/2008EP1628655A4 Antiseptic compositions, methods and systems
10/15/2008EP1613357B1 Gonadotropin releasing hormone analogue conjugates with steroid hormones
10/15/2008EP1569623B1 A topical nanoparticulate spironolactone formulation
10/15/2008EP1466614B1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon
10/15/2008EP1465617B1 Process for affecting neurologic progression
10/15/2008EP1415663B1 Sustained release hgf hydrogel preparations
10/15/2008EP1387670B1 Immune modulation device for use in animals
10/15/2008EP1379207A4 Composition for freshening nostrils and sinus cavities
10/15/2008EP1377274B1 Drug delivery system for photosensitizers
10/15/2008EP1341556B1 Drug delivery system
10/15/2008EP1233980B1 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
10/15/2008EP1200129B1 Taste masking of oral quinolone liquid preparations using ion exchange resins
10/15/2008EP1126826B1 Multiparticulate modified release composition of methylphenidate
1 ... 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 ... 1712